We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for cannabidiol (Emerge Health Pty Ltd)
Active ingredients
cannabidiol
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
Indicated for use as adjunctive therapy of seizures associated with Dravet syndrome (DS) for patients 2 years of age and older
Therapeutic area
Neurology